Pharma companies to invest Rs 700 crore in Hyderabad

HYDERABAD: Pharmaceutical companies Granules India and Laurus Labs are all set to invest in Genome Valley in Hyderabad. Representatives of the two companies met Industries Minister KT Rama Rao on Tuesday and announced their investment plans.

Granules India, a Hyderabad based pharmaceutical company, has announced a major investment of Rs 400 crore to set up a manufacturing facility with a capacity to manufacture 10 billion units of finished dosages. The proposed unit will generate employment for about 1,600 people.

Granules India has manufacturing sites in eight locations and presence in 75 countries across the globe. The company already operates the world’s largest Commercial Pharmaceutical Formulation Intermediates (PFI) Facility at Gagillapur near Hyderabad.

Krishna Prasad Chigurupati, chairman and managing director of Granules India Ltd, met IT and Industries Minister KT Rama Rao at Pragathi Bhavan and formally announced their investment plans.

In a related development, Laurus Labs, a leading research driven pharmaceutical company, has announced the setting up of a formulation facility with a unit capacity of 5 billion. The company plans to invest Rs 300 crore in two phases of Rs 150 crore each. Phase one of the plant is expected to provide employment to about 150 people.

Satyanarayana Chava, CEO, Laurus Labs, met Industries Minister Rama Rao on Tuesday, along with his team before making this announcement. Industries Department Principal Secretary Jayesh Ranjan was also present in the meeting.

Laurus Labs has its R&D facility in IKP Knowledge Park, Hyderabad, and also operates six manufacturing facilities in Visakhapatnam in Andhra Pradesh. All these facilities have been certified and approved by WHO, USFDA, NIP Hungary, and other renowned agencies.

Laurus Labs is one of the leading manufacturers of API for Anti-Retroviral (ARV), Oncology, Cardio-vascular, Anti-Diabetics, Anti-Asthma and Gastroenterology.

Industries Minister Rama Rao thanked the leadership of both Granules India and Laurus Labs for choosing to invest in Telangana. He said the Telangana government will provide all possible support to both these companies.

The minister said the proactive policies of the state government under the leadership of Chief Minister K Chandrasekhar Rao are attracting global leaders in IT, Pharma, Textiles, Aerospace and Defence and other sectors to Hyderabad and other parts of Telangana. He expressed confidence that these investments in the manufacturing sector will provide much needed employment to local youth from Telangana.

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year